S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:TAK

Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

$16.21
+0.09 (+0.56%)
(As of 06/9/2023 ET)
Compare
Today's Range
$16.16
$16.28
50-Day Range
$15.84
$17.11
52-Week Range
$12.28
$17.15
Volume
1.64 million shs
Average Volume
2.48 million shs
Market Capitalization
$51.30 billion
P/E Ratio
21.05
Dividend Yield
1.67%
Price Target
$24.67
Skip Charts & View Estimated and Actual Earnings Data

TAK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TAK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Takeda Pharmaceutical Analyst Forecasts

Current Year EPS Consensus Estimate: $0.33 EPS

TAK Earnings Date and Information

Takeda Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 27th, 2023 based off prior year's report dates.

Takeda Pharmaceutical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/27/2023
(Estimated)
        
2/2/2023Q3 2023$0.46+$0.46$0.63$8.40 billion
10/27/2022Q2 2023$0.52+$0.52$0.90$7.26 billion  
7/28/2022Q1 2023$0.56+$0.56$0.86$7.51 billion
5/11/2022Q4 2022$0.38+$0.38$0.79$7.19 billion
2/3/2022Q3 2022$0.54+$0.54$0.91$8.21 billion    
10/28/2021Q2 2022$0.45+$0.45$0.77$7.67 billion
7/30/2021Q1 2022$0.51+$0.51$0.44$8.68 billion    
5/11/2021Q4 2021$0.41+$0.41$0.23$7.27 billion
2/4/2021Q3 2021$0.56+$0.56$0.84$8.01 billion
10/29/2020Q2 2021$0.47+$0.47$0.93$7.43 billion
7/31/2020Q1 2021$0.57+$0.57$0.89$7.46 billion
5/13/2020Q4 2020$0.13+$0.13$0.25$7.09 billion
2/4/2020Q3 2020$0.53+$0.53$1.03$7.90 billion  
10/31/2019Q2 2020$0.59+$0.59$1.02$7.56 billion  
7/31/2019Q1 2020$0.56+$0.56$1.18$7.73 billion
5/14/2019Q4 2019$0.13+$0.13$0.13$3.51 billion
2/1/2019Q3 2019$0.75+$0.75$1.29$4.43 billion
10/31/2018Q2 2019$0.61+$0.61$0.94$3.86 billion
7/31/2018Q1 2019$0.69+$0.69$0.92$4.12 billion
5/14/2018Q4 2018($0.32)($0.32)($0.32)$3.70 billion
2/1/2018Q3 2018$0.39+$0.39$0.39$4.33 billion
11/1/2017Q2 2018$0.46+$0.46$0.76$3.91 billion
7/28/2017Q1 2018$0.47+$0.47$0.10$4.04 billion
5/10/2017Q4 2017($0.29)($0.29)($0.29)$3.66 billion
2/1/2017Q3 2017$0.24+$0.24$0.24$4.27 billion
10/28/2016Q2 2017$0.16+$0.16$0.16$4.07 billion
7/29/2016Q1 2017$0.59+$0.59$0.59$4.02 billion
5/10/2016Q4 2016$0.07+$0.07$0.33$3.59 billion
2/3/2016Q3 2016$0.31+$0.31$0.31$4.06 billion
10/30/2015Q2 2016$0.15+$0.15$0.15$3.75 billion
7/30/2015Q1 2016$0.13+$0.13$0.13$3.66 billion
5/15/2015Q4 2015$0.05+$0.05$1.30$3.67 billion
2/5/2015Q3 2015$0.10+$0.10$0.10$4.15 billion
10/30/2014Q2 2015$0.16+$0.16$0.16$4.08 billion
8/1/2014Q1 2015$0.21+$0.21$0.21$4.02 billion
5/8/2014Q4 2014($0.03)($0.03)($0.03)$3.98 billion
2/5/2014Q3 2014$0.29+$0.29$0.29$4.53 billion
10/31/2013Q2 2014$0.14+$0.14$0.05$4.22 billion
7/31/2013Q1 2014$0.20+$0.20$0.21$4.17 billion
5/9/2013Q4 2013$0.54+$0.54$0.79$3.72 billion












Takeda Pharmaceutical Earnings - Frequently Asked Questions

When is Takeda Pharmaceutical's earnings date?

Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 27th, 2023 based off last year's report dates. Learn more on TAK's earnings history.

How much revenue does Takeda Pharmaceutical generate each year?

Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $4.03 trillion.

How much profit does Takeda Pharmaceutical generate each year?

Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $2.35 billion. TAK has generated $0.77 earnings per share over the last four quarters.

What is Takeda Pharmaceutical's price-to-earnings ratio?

Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 21.05 and a forward price-to-earnings ratio of 49.12. The price/earnings-to-growth ratio is 9.05.

More Earnings Resources from MarketBeat

This page (NYSE:TAK) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -